US Drug Recall Register

FDA Drug Recalls

1,523 recalls · Class III, newest first

Class III · Low risk Terminated

Penicillin V Potassium for Oral Solution

Reason Failed Impurities/Degradation Specifications: high out of specification test results obtained for individual and total impurities.

Teva Pharmaceuticals USA NDC 0093-4125-73 D-0108-2018
Class III · Low risk Terminated

Isradapine Capsules USP 2.5 mg

Reason Failed Impurities/Degradation Specifications

Elite Laboratories Inc. NDC 42806-263-01 D-0107-2018
Class III · Low risk Terminated

Fluconazole Injection

Reason Superpotent

Renaissance Lakewood, LLC NDC 33600-002-10 D-0124-2018
Class III · Low risk Terminated

Ciprofloxacin in Dextrose

Reason Superpotent

Claris Lifesciences Inc NDC 36000-008-24 D-0127-2018
Class III · Low risk Terminated

Dexamethasone Sodium Phosphate Injection

Reason Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).

West-Ward Pharmaceuticals Corp. NDC 0641-6146-01 D-0094-2018
Class III · Low risk Terminated

Dexamethasone Sodium Phosphate Injection

Reason Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).

West-Ward Pharmaceuticals Corp. NDC 0641-6145-01 D-0093-2018
Class III · Low risk Terminated

bupPROPion HCL Extended-Release Tablets

Reason Failed Impurities/Degradation Specifications: Mylan Pharmaceuticals Inc. is conducting a voluntary recall due to related out of specification compound results obtained during routine stability testing.

Mylan Pharmaceuticals Inc. D-0230-2018
Class III · Low risk Terminated

Meclizine hydrochloride tablets USP

Reason Marketed without an approved NDA/ANDA: Bottles were released prior to final approval.

Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-122-06 D-0082-2018
Class III · Low risk Terminated

Doan's Pain Relieving Cream with 4% Lidocaine Plus Menthol

Reason Labeling: Incorrect or Missing Lot and/or Exp Date; lot number on the secondary packaging doesnt match the lot number printed on the bottle

Dr. Reddy's Laboratories, Inc. D-0072-2018
Class III · Low risk Terminated

Lumigan

Reason Failed Impurities/Degradation Specifications.

Allergan Sales, LLC NDC 0023-3205-03 D-0078-2018
Class III · Low risk Terminated

Combigan

Reason Failed Impurities/Degradation Specifications.

Allergan Sales, LLC NDC 0023-9211-03 D-0077-2018
Class III · Low risk Terminated

Methylphenidate Hydrochloride Tablets USP

Reason Failed Dissolution Specifications: Low out of specification results for dissolution.

Teva Pharmaceuticals USA NDC 0591-5884-01 D-0052-2018
Class III · Low risk Terminated

Clofarabine injection

Reason Labeling: Incorrect or Missing Package Insert: authorized generic product was packaged with the incorrect insert for the brand name product Clolar (clofarabine) injection.

Sanofi-Aventis U.S. LLC NDC 0955-1746-01 D-0056-2018
Class III · Low risk Terminated

Clolar

Reason Labeling: Incorrect or Missing Package Insert.

Genzyme Corporation NDC 0024-5860-01 D-0075-2018
Class III · Low risk Terminated

Famotidine tablets

Reason Failed impurities/degradation specifications: Famotodine has an out of specification result for an individual related substance observed during routine stability testing of a batch for related substances -impurity 8 at 24 month stability interval.

Dr. Reddy's Laboratories, Inc. NDC 55111-118-30 D-0009-2018
Class III · Low risk Terminated

Esterified Estrogens & Methyltestosterone Tablets

Reason Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.

Amneal Pharmaceuticals, Inc. NDC 13925-172-01 D-1439-2019
Class III · Low risk Terminated

Esterified Estrogens & Methyltestosterone Tablets

Reason Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.

Amneal Pharmaceuticals, Inc. NDC 13925-171-01 D-1438-2019
Class III · Low risk Terminated

Ampicillin for Injection

Reason Labeling: Missing Label: customer complaint that some vials of ampicillin within the shrink wrap pack are missing labels.

Sandoz Inc NDC 0781-3407-78 D-1179-2017
Class III · Low risk Terminated

Carbamazepine Oral Suspension USP

Reason Subpotent Drug: low out of specification results.

Precision Dose Inc. NDC 68094-301-59 D-0057-2018
Class III · Low risk Terminated

Mobic

Reason Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.

Boehringer Ingelheim Pharmaceuticals, Inc. NDC 0597-0030-01 D-0007-2018